Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan

Broadly neutralizing ability is critical for developing the next-generation SARS-CoV-2 vaccine. We collected sera samples between December 2021-January 2022 from 113 Taiwan naïve participants after their second dose of homologous vaccine (AZD1222, mRNA-1273, BNT162-b2, and MVC-COV1901) and compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Chao, Chiao-Hsuan, Cheng, Dayna, Huang, Sheng-Wen, Chuang, Yung-Chun, Yeh, Trai-Ming, Wang, Jen-Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705976/
https://www.ncbi.nlm.nih.gov/pubmed/36458016
http://dx.doi.org/10.3389/fimmu.2022.1023943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705976/
https://www.ncbi.nlm.nih.gov/pubmed/36458016
http://dx.doi.org/10.3389/fimmu.2022.1023943

Ejemplares similares